SLU-PP-332 5mg
$125.00SLU-PP-332 is an experimental small-molecule peptide investigated for its ability to influence metabolic pathways tied to cellular energy production and healthy aging. Early research suggests activation of exercise-mimetic signaling via
SS-31 10mg
$116.00
SS-31 50mg
$195.00
TB-500 10mg
$64.00TB-500 is a synthetic version of Thymosin Beta-4, a naturally occurring protein found in many tissues throughout the body. Researchers study TB-500 for its potential role in supporting healthy tissue
Tesamorelin + Ipamorelin is a dual-pathway growth hormone research blend combining a stabilized GHRH analog with a selective growth hormone secretagogue (GHS). Tesamorelin stimulates growth hormone release through GHRH receptor
Tesamorelin 10mg
$86.00Tesamorelin is a synthetic 44–amino-acid polypeptide modeled on growth hormone–releasing hormone (GHRH), incorporating N-terminal and C-terminal modifications to enhance stability and resistance to enzymatic degradation. It binds to GHRH receptors
Thymosin Alpha-1 10mg
$130.00Thymosin Alpha-1 (Tα1) is a naturally occurring 28–amino-acid polypeptide associated with immune regulation and is one of the components found within Thymosin Fraction 5, a crude extract derived from the
Thymosin Alpha-1 5mg
$80.00Thymosin Alpha-1 (Tα1) is a naturally occurring 28–amino-acid polypeptide associated with immune regulation and is one of the components found within Thymosin Fraction 5, a crude extract derived from the
Tirz (GLP-2) 10mg
$95.00Tirzepatide is a long-acting synthetic polypeptide engineered as a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. By activating both incretin pathways, it has been
Tirz (GLP-2) 20mg
$150.00Tirzepatide is a long-acting synthetic polypeptide engineered as a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. By activating both incretin pathways, it has been
Tirz (GLP-2) 30mg
$185.00Tirzepatide is a long-acting synthetic polypeptide engineered as a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. By activating both incretin pathways, it has been
